Bird-Headed Dwarfism, Montreal Type

Bird-headed dwarfism, Montreal type is an extremely rare, multi-system genetic disorder first described in Montreal in 1970. It causes very short stature (dwarfism) that becomes obvious after birth, a small head (microcephaly), and a characteristic “bird-like” facial profile with a narrow face, big eyes, a prominent or beak-like nose, and a receding chin. People described in the original report also had premature aging features (such as early graying and loss of scalp hair and wrinkled palms), skeletal abnormalities, undescended testes (cryptorchidism) in males, and progressive problems with thinking and memory described as premature senility or early-onset dementia. Intellectual disability can vary in severity. The condition is considered a form of microcephalic primordial dwarfism (a group of disorders with very small body and head size) and has been recognized as a distinct entity, separate from but superficially resembling Seckel syndrome and a few other “bird-headed” conditions. Only the original Montreal description has been firmly documented, highlighting just how rare this diagnosis is. Orpha+2Wikipedia+2

Bird-headed dwarfism, Montreal type is a very rare, inherited condition that affects the whole body. Children are usually very small for their age (severe short stature) and have a small head (microcephaly). The face often looks narrow with a beak-like, prominent nose, large-appearing eyes, and a small lower jaw. Doctors sometimes describe the overall look as “bird-headed.” Other common features reported include early graying and loss of scalp hair, dry and wrinkled skin on the palms, and learning or thinking problems that can range from mild to more severe. Some people may have undescended testes (cryptorchidism) and skeletal differences. These features were first described in a patient seen in Montreal in 1970, and there have been very few additional detailed case descriptions since then, which makes strong, evidence-backed generalizations difficult. Genetic & Rare Diseases Info Center+2Orpha+2

Bird-headed dwarfism, Montreal type is a very rare genetic condition first described in Montréal in 1970. Children have normal weight at birth but later develop severe short height, a very small head (microcephaly), a narrow “bird-like” face, big eyes, a prominent nose, thin or receding chin, and sometimes a cleft or high-arched palate. Other features can include early graying or loss of hair, wrinkled palms, undescended testes (cryptorchidism), learning difficulties, and early memory problems. Only the original case series is firmly documented in the literature, and no specific gene or cure has been proven for this exact type. Care is therefore supportive and symptom-based, often borrowing best practices from closely related syndromes such as Seckel syndrome (a microcephalic primordial dwarfism sometimes called “bird-headed dwarfism”). Wikipedia+3Genetic & Rare Diseases Info Center+3Orpha+3

Another names

Doctors and reference centers use a few names for the same disorder. You may see:

• Bird-headed dwarfism, Montreal type

• Microcephalic primordial dwarfism, Montreal type
  These terms refer to the same syndrome first reported by Fitch and colleagues in Montreal. Some sources discuss it alongside Seckel syndrome (also called “bird-headed dwarfism” more generally), but the Montreal type has been kept separate because the original case had features not fully explained by Seckel syndrome. Genetic & Rare Diseases Info Center+1

Types

Within bird-headed dwarfism, Montreal type, no official subtypes have been established because so few cases have been reported. It sits within the larger family of microcephalic primordial dwarfism (MPD) disorders and has clinical overlap with Seckel syndrome and other MPD conditions. Those related MPD conditions have multiple genetic subtypes (for example ATR-related Seckel type 1; CENPJ-related Seckel type 4; CEP152-related Seckel type 5; and others), but the specific gene for the Montreal type has not been confirmed. Orpha+1

Causes

Because only the original Montreal case is well documented, scientists have not pinned down a single gene for this exact type. Still, medical genetics gives us a safe, evidence-based way to explain how and why similar disorders happen. Below are 20 plainly worded “causes or causal mechanisms,” grouped to keep accuracy while being honest about the limits of current knowledge:

1. Pathogenic genetic variant (mutation): the root cause is a disease-causing change in DNA affecting growth and brain development. Montreal type is regarded as genetic. Genetic & Rare Diseases Info Center

2. Autosomal recessive inheritance (likely): most similar MPD/Seckel-like disorders are recessive, meaning both copies of a gene are altered; parents can be healthy carriers. This is probable for Montreal type by analogy, though unproven specifically. Wikipedia

3. De novo variant: sometimes the disease-causing change appears for the first time in the child (not inherited). This is a general mechanism recognized for genetic disease. Genetic & Rare Diseases Info Center

4. DNA damage-response pathway defects (hypothesized): many Seckel/MPD genes are in the cell’s DNA repair/checkpoint systems (e.g., ATR pathway). A similar pathway defect could underlie Montreal type. PubMed+1

5. Centrosome/mitotic spindle defects (hypothesized): several MPD genes help cells divide correctly; disruption can stunt overall and brain growth. PubMed

6. ATR gene pathway (analogy to Seckel): ATR mutations cause a classic Seckel subtype; while not proven for Montreal type, this illustrates a plausible mechanism. Wikipedia

7. CENPJ gene pathway (analogy): CENPJ defects cause Seckel type 4—again, a mechanistic clue rather than a confirmed Montreal-type gene. PubMed

8. CEP152 gene pathway (analogy): CEP152 variants can cause Seckel type 5 and primary microcephaly; this points to centrosomal biology in these disorders. Wikipedia+1

9. RBBP8 (CtIP) pathway (analogy): RBBP8 mutations are known in Seckel/Jawad syndromes; relevant because they disturb DNA break repair. PLOS

10. CEP63 / NIN / DNA2 / TRAIP / NSMCE2 / CEP295 pathways (analogy): additional genes tied to Seckel subtypes and MPD stress the theme of DNA repair and centrosome function. Wikipedia+1

11. Consanguinity (risk factor): when parents are related, the chance of a recessive disorder rises; this is a general risk factor for MPD/Seckel-like diseases. Little People of Ontario

12. Parental carrier status: healthy carriers can pass on a recessive variant; two carriers have a 25% chance in each pregnancy. (General genetics principle.) Wikipedia

13. Random (sporadic) events in egg/sperm: copying errors during cell division can create a pathogenic variant even without family history. Genetic & Rare Diseases Info Center

14. Environmental mutagens (general mechanism): UV or certain chemicals can create DNA changes in germ cells; GARD notes environment can contribute to mutations, though this is not a direct environmental disease. Genetic & Rare Diseases Info Center

15. Viral influence on mutation (general mechanism): infections can sometimes lead to DNA changes; again, a background mechanism rather than a direct cause. Genetic & Rare Diseases Info Center

16. Epigenetic disturbances (hypothesized): unusual switching on/off of growth-related genes may modify severity in genetic microcephaly/dwarfism disorders. (Inference from MPD biology.) PubMed

17. Embryonic cell-cycle dysregulation: many MPD genes regulate cell cycle; defective control reduces neuron numbers and body growth. PubMed

18. Developmental brain growth failure: microcephaly results when neural progenitor cells cannot proliferate normally due to the above mechanisms. PubMed

19. Skeletal growth plate dysregulation: centrosome/mitosis defects can limit chondrocyte proliferation, contributing to short stature. (Mechanistic inference from MPD/Seckel literature.) OUP Academic

20. A yet-undiscovered gene: because Montreal type is so rare, the responsible gene may simply not have been identified yet. Reference centers still label the cause as “genetic mutation.” Orpha+1

Important honesty note: items 4–10, 16–19 summarize well-studied causes in closely related Seckel/MPD conditions and are provided to explain probable mechanisms; they are not confirmed for the Montreal type itself.

Symptoms

Below are common and reported features; any one person might not have all of them:

1. Very short height that becomes obvious in childhood, often with normal birth weight but poor postnatal growth. Wikipedia

2. Small head (microcephaly) measured below standard charts for age and sex. Orpha

3. Narrow “bird-like” face with big eyes, prominent nose, and receding chin. Wikipedia

4. Early graying and hair loss of the scalp, sometimes in adolescence or young adulthood. Orpha

5. Wrinkled, dry palms, giving an aged appearance to the hands. Orpha

6. Skeletal abnormalities, which may include limb or spine differences contributing to short stature or posture changes. Orpha

7. Undescended testes (cryptorchidism) in males. Wikipedia

8. Learning difficulties or intellectual disability of variable severity. Wikipedia

9. Early memory and thinking problems (described as premature senility/early-onset dementia) in the historical report. Wikipedia

10. Low-set ears and small or under-formed earlobes. Wikipedia

11. Abnormally small brain on imaging (a structural correlate of microcephaly). Wikipedia

12. Prominent nose and narrow midface giving the “bird-headed” profile. Orpha

13. Feeding difficulties and low weight gain in infancy/childhood, common in primordial dwarfism groups (clinical inference from MPD). Orpha

14. Motor development delay (sitting, standing, walking later than peers), frequently seen in microcephalic primordial dwarfism. Orpha

15. Behavioral or social challenges secondary to developmental delay or cognitive impairment. (General MPD experience.) Orpha

 

Non-pharmacological treatments (therapies & other care)

1) Coordinated care at a multidisciplinary clinic
Purpose: To bring pediatrics, genetics, neurology, ENT, ophthalmology, dentistry, orthopedics, nutrition, speech and occupational therapy into one plan. How it helps: When many body systems are involved, care often fragments. A team clinic prevents missed problems, schedules the right tests, and times treatments such as palatal repair, ear tubes, or orchiopexy appropriately. Mechanism: Better outcomes come from early detection and sequencing of interventions across childhood, which cleft/craniofacial and rare-disease programs strongly recommend. ACPA+1

2) Early intervention (physical, occupational, and speech therapy)
Purpose: To support motor skills, feeding, speech, and daily activities. How it helps: Microcephaly and craniofacial differences can delay milestones and speech. Therapists teach exercises, safe feeding positions, and communication strategies. Mechanism: Repeated guided practice builds neural pathways and compensates for structural limits, improving function and reducing caregiver strain. Genetic & Rare Diseases Info Center

3) Individualized education plan (IEP) and cognitive supports
Purpose: To match classroom demands to attention, memory, and processing speed. How it helps: Small class size, visual supports, and extra time can turn hard tasks into achievable ones. Mechanism: Structured cues and predictable routines lower cognitive load and help children form stable learning habits. Genetic & Rare Diseases Info Center

4) Nutritional counseling and growth monitoring
Purpose: To prevent under-nutrition, vitamin/mineral deficiencies, and aspiration with a small jaw or cleft palate. How it helps: Dietitians adjust calories, texture (purees/soft foods), and feeding frequency; they also time meals around therapies and medications. Mechanism: Adequate protein, calcium, vitamin D, and micronutrients support bone, immune function, and energy; careful textures lower choking risk. Genetic & Rare Diseases Info Center+1

5) Swallow and feeding therapy
Purpose: To make eating safe and efficient when the palate or jaw shape makes swallowing hard. How it helps: Therapists teach posture, pacing, nipple/utensil selection, and texture progression. Mechanism: Positioning and texture change the physics of the swallow, reducing aspiration and improving calories taken by mouth. PMC

6) Hearing management and tympanostomy-tube evaluation
Purpose: To prevent speech delay from repeated ear fluid/infections. How it helps: Regular hearing tests and, when indicated, ear tubes improve sound transmission and reduce infections. Mechanism: Tubes ventilate the middle ear and drain fluid; guidelines outline which children benefit. AAO-HNS+1

7) Vision care and strabismus management
Purpose: To optimize visual acuity and eye alignment for development and safety. How it helps: Glasses, patching, and sometimes surgery improve alignment and depth perception. Mechanism: Correcting misalignment improves binocular vision; surgical repositioning of eye muscles can restore alignment. AAPOS+1

8) Dental and craniofacial care
Purpose: To address crowding, enamel issues, and bite problems common in micrognathia/high-arched palate. How it helps: Preventive dentistry plus orthodontics and, when needed, surgical repair of cleft palate improve feeding, speech, and oral health. Mechanism: Repair closes the palate to separate mouth from nose; orthodontics guides jaw/teeth growth for safer chewing. AAPD+1

9) Ketogenic or modified Atkins diet in drug-resistant epilepsy (when present)
Purpose: To reduce seizures that do not respond to medicine. How it helps: High-fat, low-carb diets shift brain fuel to ketones, which can stabilize neuronal firing. Mechanism: Ketosis alters neurotransmitters and neuronal excitability; must be run by a specialist team because growth can be affected. PMC+1

10) Genetic counseling for families
Purpose: To explain inheritance, recurrence risk, and options (carrier testing, prenatal/early postnatal evaluation). How it helps: Families can plan future pregnancies with realistic expectations. Mechanism: Pedigree review and test selection clarify risk even when the exact gene for this historic subtype is not known. Genetic & Rare Diseases Info Center+1

11) Sleep and breathing assessment
Purpose: To detect obstructive sleep apnea from small jaw or airway crowding. How it helps: Positioning, dental appliances, or ENT interventions can improve sleep, growth, and daytime focus. Mechanism: Opening the airway reduces intermittent hypoxia and sleep fragmentation. PMC

12) Psychosocial and caregiver support
Purpose: To reduce burnout and improve participation in therapy plans. How it helps: Social work links families to services, transport, equipment, and respite care. Mechanism: Consistent supports increase adherence and quality of life. Genetic & Rare Diseases Info Center

---

Drug treatments

There are no FDA-approved drugs for the disease itself. Medicines are used only for specific complications (for example, seizures or spasticity), and dosing must be individualized by the treating clinician. The FDA labels below provide the evidence basis for indications, dosing ranges, contraindications, and adverse effects. Use is for the symptom, not as a cure for this syndrome. Genetic & Rare Diseases Info Center+1

Below are representative options often used for common complications (e.g., epilepsy, spasticity). Labels are from accessdata.fda.gov; details are summarized in simple English. Always prescribe and monitor under specialist care.

1) Levetiracetam (Keppra®/Spritam®) — anti-seizure
Class: Antiepileptic. Typical dosage/time: Oral dosing is weight-based and titrated; IV options exist for hospital use. Purpose: Reduce focal and generalized seizures. How it works: Modulates synaptic vesicle protein SV2A to steady neuronal firing. Side effects: Sleepiness, fatigue, behavior changes; dosing and renal function adjustments per label. Evidence source: FDA labels for levetiracetam products. FDA Access Data+2FDA Access Data+2

2) Valproate (Depakene®/Depacon®) — anti-seizure
Class: Broad-spectrum antiepileptic. Dosage/time: Weight-based; oral or IV; careful serum level monitoring. Purpose: Treat absence, generalized, and focal seizures. How it works: Increases GABA and stabilizes neuronal firing. Side effects/warnings: Liver toxicity, pancreatitis, teratogenicity; pregnancy precautions are strict. Evidence source: FDA labels. FDA Access Data+2FDA Access Data+2

3) Clonazepam (Klonopin®) — anti-seizure/anti-myoclonic
Class: Benzodiazepine. Dosage/time: Low dose, slowly titrated; oral tablets. Purpose: Control absence and myoclonic seizures. How it works: Enhances GABA-A receptor activity to calm overactive circuits. Side effects: Sedation, dependence, respiratory depression with other CNS depressants; tapering needed. Evidence source: FDA labels. FDA Access Data+1

4) Midazolam nasal spray (Nayzilam®) — seizure-cluster rescue
Class: Benzodiazepine rescue therapy. Dosage/time: 5 mg intranasal; may repeat once; limits on frequency apply. Purpose: Stop dangerous seizure clusters at home or school. How it works: Rapid GABA-A enhancement aborts seizure activity. Side effects: Drowsiness, breathing suppression—caregiver training required. Evidence source: FDA label and approval letter. FDA Access Data+2FDA Access Data+2

5) Baclofen (oral suspension/tablet) — spasticity management
Class: GABA-B agonist muscle relaxant. Dosage/time: Start low and titrate; avoid abrupt stop. Purpose: Reduce tone that interferes with movement, hygiene, or sleep. How it works: Decreases excitatory neurotransmitter release in spinal cord. Side effects: Sleepiness, dizziness, withdrawal risk if stopped suddenly. Evidence source: FDA labels (Fleqsuvy®, Ozobax®, Lyvispah®). FDA Access Data+2FDA Access Data+2

(If your patient has other specific complications—e.g., reflux, constipation, anxiety, ADHD—those medicines should be chosen by the treating specialist using standard FDA-labeled products for those conditions; I can enumerate more with labels on request.)

---

Dietary molecular supplements

1) Vitamin D (with calcium from food)
Why/what it does: Supports bone strength and calcium balance when growth is small, feeding is selective, or outdoor sun is limited. Dose: RDA varies by age (generally 400–800 IU/day; avoid >4,000 IU/day without medical advice). Function/mechanism: Vitamin D helps the gut absorb calcium and maintains bone mineralization; levels are checked as 25-OH vitamin D. Note: Too much can cause high calcium and kidney strain—use lab-guided dosing. Office of Dietary Supplements+1

2) Omega-3 fatty acids (EPA/DHA)
Why/what it does: General cardiovascular and anti-inflammatory support; sometimes used as an adjunct in neurodevelopmental care though not disease-specific. Dose: Common supplements provide 250–1,000 mg/day EPA+DHA; food sources are preferred. Function/mechanism: Incorporate into neuronal membranes, modulate eicosanoids, and lower triglycerides. Evidence note: Benefits are condition-specific; discuss with clinicians to avoid interactions and to set realistic expectations. Office of Dietary Supplements+1

3) Folate (vitamin B9)
Why/what it does: Critical for DNA synthesis and cell division; relevant for family planning and general health. Dose: Age-appropriate RDA; women who could become pregnant typically need 400 mcg folic acid daily. Function/mechanism: Supports one-carbon metabolism and methylation pathways; proven to reduce neural-tube-defect risk when taken periconceptionally. Office of Dietary Supplements+1

---

Immunity-booster / regenerative / stem-cell drugs

There are no FDA-approved “immunity-boosting,” “regenerative,” or stem-cell drugs for Bird-headed dwarfism/Montreal type, and none should be given outside an approved clinical trial. Using unregulated products risks serious harm. Immune health is best supported by routine vaccinations, nutrition, good sleep, dental care, and infection-prevention habits, plus prompt treatment of infections. If you’re interested in research trials for primordial dwarfism or related microcephalic syndromes, I can help search registries and eligibility criteria. Genetic & Rare Diseases Info Center+1

---

Surgeries

1) Orchiopexy for undescended testis
What/why: Moves a testis into the scrotum and fixes it there to protect fertility potential and allow easier exam. Why it’s done: Cryptorchidism raises risks for subfertility and torsion; early repair (often 6–12 months) is guideline-supported. AUA Journals+1

2) Cleft palate repair
What/why: Closes a gap in the roof of the mouth to improve feeding, speech, and ear health. Why it’s done: Repair between ~6–12 months is commonly practiced in cleft centers; exact timing is individualized. PMC+1

3) Strabismus surgery
What/why: Repositions eye muscles to straighten the eyes. Why it’s done: Improves alignment, depth perception, and quality of life when glasses/patching are not enough. PubMed+1

4) Tympanostomy (ear) tubes
What/why: Small tubes in the eardrum allow air flow and drainage to reduce ear infections and improve hearing. Why it’s done: Indicated in selected children with persistent effusions or recurrent infections per evidence-based guidelines. AAO-HNS+1

5) Orthognathic or airway procedures (select cases)
What/why: Jaw advancement or airway surgery to treat severe obstructive sleep apnea or feeding problems when conservative options fail. Why it’s done: To secure breathing during sleep and improve growth, behavior, and daytime function. PMC

---

Preventions

1. Pre-pregnancy genetic counseling for families with a history or concern. Prevents surprise by clarifying recurrence risk and testing options. Genetic & Rare Diseases Info Center

2. Carrier or targeted testing when available for related microcephalic dwarfism genes; informs future planning. Genetic & Rare Diseases Info Center

3. Prenatal/early postnatal evaluation in at-risk pregnancies; allows early supportive care. Genetic & Rare Diseases Info Center

4. Standard immunizations to reduce infection burden. Genetic & Rare Diseases Info Center

5. Nutrition optimization (calcium/vitamin D and adequate protein). Office of Dietary Supplements

6. Hearing surveillance to prevent speech delay from silent fluid. AAO-HNS

7. Dental prevention (fluoride, hygiene, early orthodontic review). AAPD

8. Vision screening for strabismus/amblyopia. AAO Journal

9. Sleep screening for snoring/apneas in small jaw/cleft palate. PMC

10. Injury prevention (appropriate car seats, helmets, safe mobility aids) tailored to short stature. Genetic & Rare Diseases Info Center

---

When to see a doctor

Seek urgent care for seizures, choking or blue lips during feeds, pauses in breathing during sleep, fast worsening headaches, repeated vomiting, high fever, or dehydration. Make a prompt appointment for new hearing or vision loss, frequent ear infections, poor weight gain, sleep snoring with daytime sleepiness, or undescended testis not in the scrotum by 6–12 months. Regular follow-up with your pediatrician, genetics, ENT, dental/orthodontic, neurology, ophthalmology, and therapy teams is essential because early action prevents bigger problems later. AAO-HNS+2AUA Journals+2

---

What to eat and what to avoid

Eat/do:

1. Balanced meals with protein at each meal to support growth. Genetic & Rare Diseases Info Center

2. Calcium-rich foods (dairy/fortified alternatives) and vitamin-D per age to keep bones strong. Office of Dietary Supplements

3. Iron-rich foods (meats/legumes/fortified cereals) if labs show low iron. Genetic & Rare Diseases Info Center

4. Soft or modified textures if chewing/swallowing is hard; use therapy guidance. PMC

5. Omega-3 sources (fish, flax, walnuts) for general health. Office of Dietary Supplements

Avoid/limit:

1. Large, dry chunks that increase choking risk (nuts, hard raw veggies) without proper preparation. PMC
2. Excess added sugar and ultra-processed snacks that displace needed nutrients. Genetic & Rare Diseases Info Center
3. High-dose, unsupervised vitamin D—risk of toxicity; test and dose medically. Office of Dietary Supplements
4. Caffeine and energy drinks in children. Genetic & Rare Diseases Info Center
5. Unproven “immune boosters” or stem-cell products outside trials. Genetic & Rare Diseases Info Center

(If drug-resistant epilepsy is present, a supervised ketogenic plan may be considered; note growth effects and need for supplements.) PMC+1

---

Frequently asked questions

1) Is there a cure?
No. Care focuses on screening and treating each problem early to improve daily life and long-term function. Genetic & Rare Diseases Info Center

2) Is this the same as Seckel syndrome?
It overlaps in appearance (“bird-headed dwarfism”), but “Montreal type” refers to a distinct historic series; only a few cases were ever reported. Wikipedia

3) What causes it?
It’s genetic, but a specific causative gene for the Montréal type has not been established; related microcephalic dwarfisms have multiple genes. Orpha+1

4) Can growth hormone help?
There’s no evidence it helps in microcephalic primordial dwarfism; decisions must be specialist-led. Genetic & Rare Diseases Info Center

5) Are there approved stem-cell or regenerative drugs?
No. Avoid unregulated offerings; look for clinical trials instead. Genetic & Rare Diseases Info Center

6) How are seizures treated if they occur?
With standard antiepileptic medicines and, if needed, dietary therapies or rescue sprays as per FDA labels and epilepsy guidelines. FDA Access Data+1

7) Why repair a cleft palate early?
To improve feeding, speech, ear health, and growth. Timing is individualized but often within the first year. PMC

8) Why consider ear tubes?
Persistent middle-ear fluid damages hearing and speech; tubes ventilate and drain to protect language development. AAO-HNS

9) Do undescended testes need surgery?
Yes—orchiopexy improves exam, lowers some risks, and supports fertility potential when done early. AUA Journals+1

10) How often should eyes be checked?
Regularly in early childhood; strabismus or refractive errors should be treated to protect vision. AAO Journal

11) Can nutrition really make a difference?
Yes—adequate protein, calcium, and vitamin D support bones and growth; texture changes can prevent choking. Office of Dietary Supplements+1

12) Are vaccines safe and important?
Yes—standard immunizations reduce infections that can worsen growth and development. Genetic & Rare Diseases Info Center

13) Is the ketogenic diet right for everyone with seizures?
No—it’s reserved for drug-resistant epilepsy and must be supervised; growth must be monitored. PMC+1

14) What specialists should be on the team?
Pediatrics, genetics, neurology, ENT, ophthalmology, dentistry/orthodontics, nutrition, speech/OT/PT, and social work. ACPA

15) What’s the long-term outlook?
It varies; early, coordinated care improves function and quality of life even without a cure. Genetic & Rare Diseases Info Center

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 26, 2025.

PDF Documents For This Disease Condition References